Rani Therapeutics GAAP EPS of -$0.04 in-line, revenue of $1.7M beats by $1.2M (NASDAQ:RANI)

Rani Therapeutics press release (RANI): Q1 GAAP EPS of -$0.04 in-line. Revenue of $1.7M (+900.0% Y/Y) beats by $1.2M. Cash, cash equivalents and marketable secu

Read on WOBR AI →